Regulation of plasminogen activators in connective tissues: Potential for thrombolytic therapy in collagen-vascular diseases
- 31 January 1992
- journal article
- Published by Elsevier in Fibrinolysis
- Vol. 6, 43-48
- https://doi.org/10.1016/0268-9499(92)90093-w
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Decreased fibrinolytic activity in juvenile chronic arthritis.Annals of the Rheumatic Diseases, 1990
- Imbalance between the mechanisms of activation and inhibition of metalloproteases in the early lesions of experimental osteoarthritisArthritis & Rheumatism, 1990
- FIBRINOLYTIC ACTIVITY IN THE SYNOVIAL MEMBRANE OF OSTEOARTHRITISRheumatology, 1990
- Prolonged improvement of raynaud's phenomenon and scleroderma after recombinant tissue plasminogen activator therapyArthritis & Rheumatism, 1990
- Lung disease in cystic fibrosis—an updated conceptPediatric Pulmonology, 1990
- Local abnormalities of coagulation and fibrinolytic pathways that promote alveolar fibrin deposition in the lungs of baboons with diffuse alveolar damage.Journal of Clinical Investigation, 1989
- Modulation of urokinase‐type plasminogen activator messenger rna levels in human synovial fibroblasts by interleukin‐1, retinoic acid, and a glucocorticoidArthritis & Rheumatism, 1988
- Indications of vascular endothelial cell dysfunction in systemic lupus erythematosus.Annals of the Rheumatic Diseases, 1987
- Decreased plasma fibrinolysis in patients with rheumatoid arthritis.Annals of the Rheumatic Diseases, 1984
- Treatment of Raynaud's phenomenon by fibrinolytic enhancement.BMJ, 1978